216 related articles for article (PubMed ID: 30693001)
21. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
22. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells.
Lundie RJ; de Koning-Ward TF; Davey GM; Nie CQ; Hansen DS; Lau LS; Mintern JD; Belz GT; Schofield L; Carbone FR; Villadangos JA; Crabb BS; Heath WR
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14509-14. PubMed ID: 18799734
[TBL] [Abstract][Full Text] [Related]
23. CD8
Ghazanfari N; Gregory JL; Devi S; Fernandez-Ruiz D; Beattie L; Mueller SN; Heath WR
J Immunol; 2021 Sep; 207(6):1578-1590. PubMed ID: 34400523
[TBL] [Abstract][Full Text] [Related]
24. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature.
Swanson PA; Hart GT; Russo MV; Nayak D; Yazew T; Peña M; Khan SM; Janse CJ; Pierce SK; McGavern DB
PLoS Pathog; 2016 Dec; 12(12):e1006022. PubMed ID: 27907215
[TBL] [Abstract][Full Text] [Related]
25. Comparison of CD8
Barrera V; Haley MJ; Strangward P; Attree E; Kamiza S; Seydel KB; Taylor TE; Milner DA; Craig AG; Couper KN
Front Immunol; 2019; 10():1747. PubMed ID: 31396236
[TBL] [Abstract][Full Text] [Related]
26. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
Front Immunol; 2018; 9():997. PubMed ID: 29867974
[TBL] [Abstract][Full Text] [Related]
27. Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models.
Xu C; Zhang Y; Rolfe PA; Hernández VM; Guzman W; Kradjian G; Marelli B; Qin G; Qi J; Wang H; Yu H; Tighe R; Lo KM; English JM; Radvanyi L; Lan Y
Clin Cancer Res; 2017 Oct; 23(19):5869-5880. PubMed ID: 28679778
[No Abstract] [Full Text] [Related]
28. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
29. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
30. IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice.
Ball EA; Sambo MR; Martins M; Trovoada MJ; Benchimol C; Costa J; Antunes Gonçalves L; Coutinho A; Penha-Gonçalves C
J Immunol; 2013 May; 190(10):5118-27. PubMed ID: 23585679
[TBL] [Abstract][Full Text] [Related]
31. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
32. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.
Belnoue E; Kayibanda M; Vigario AM; Deschemin JC; van Rooijen N; Viguier M; Snounou G; Rénia L
J Immunol; 2002 Dec; 169(11):6369-75. PubMed ID: 12444144
[TBL] [Abstract][Full Text] [Related]
33. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
[TBL] [Abstract][Full Text] [Related]
34. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
35. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
36. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.
Beghdadi W; Porcherie A; Schneider BS; Dubayle D; Peronet R; Huerre M; Watanabe T; Ohtsu H; Louis J; Mécheri S
J Exp Med; 2008 Feb; 205(2):395-408. PubMed ID: 18227221
[TBL] [Abstract][Full Text] [Related]
37. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
[TBL] [Abstract][Full Text] [Related]
38. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
[TBL] [Abstract][Full Text] [Related]
39. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
40. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]